FUND
We fund healthcare industries globally.
Our latest project:
Keep up with the latest updates, insights, and opportunities driving meaningful change in the healthcare industries
Follow us
ARCHIMED is focused on accelerating the development of healthcare industries and solutions to the benefit of people and patients around the world.
people employed
by ARCHIMED companies.
ARCHIMED was founded by healthcare professionals who shared the same passion of making a true impact in the healthcare industries. Watch the video to discover the story of ARCHIMED.
We fund, support and scale companies whose activities contribute to improve health outcomes at all levels.
average annual topline growth
of ARCHIMED companies.
We join forces with scientists, healthcare professionals, entrepreneurs and investors through our 3 main activities:
We fund healthcare industries globally.
Our latest project:
We support healthcare entrepreneurs in their companies’ development.
Our latest project:
We deliver superior returns to our investors and to society.
Our latest project:
We fund healthcare industries globally.
Our latest project:
We support healthcare entrepreneurs in their companies’ development.
Our latest project:
We deliver superior returns to our investors and to society.
Our latest project:
March 11, 2025
BioVendor Group is a major player in advanced diagnostics, with expertise in immunology, infectious, metabolic, and autoimmune diseases as well as genetics research.
January 27, 2025
ARCHIMED announces the sale of DIESSE to private equity firm Fremman Capital. The transaction caps a five-year partnership with DIESSE and marks the latter’s transformation into a leading clinical diagnostics innovator. The deal returns 4.6 times invested capital to shareholders.
November 26, 2024
As part of the transaction, Nihon Kohden, one of the largest developers and distributors of medical electronic equipment in the world, is entering a joint-venture with ARCHIMED to pursue Ad-Tech’s growth in North America, Europe, and Asia.